ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Basic information
- Product Name:
- 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Synonyms:
-
- Azilsartan medoxomil impurity337
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-β-oxo-, (3R,4R)-
- Tofacitinib Imp.Y
- CAS:
- 2374700-40-8
- MF:
- C16H20N6O
- MW:
- 312.38
- Mol File:
- 2374700-40-8.mol
More
Less
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Chemical Properties
- Density
- 1.296±0.06 g/cm3(Predicted)
- pka
- 6.00±0.60(Predicted)
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrileSupplier
Beijing Comparison Pharmaceutical Technology Co., Ltd
- Tel
- 010-52878169 15701683040
- sales@bjcomparison.com
Shijiazhuang yaoBo Pharmaceutical Co., Ltd.
- Tel
- 15633056635
- 2880679888@qq.com
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd
- Tel
- 15850510341
- shiqingran@wzxchem.com
Wuxi Helen Biotechnology Co., Ltd.,
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com
Foshan Treasure Biotechnology Co., Ltd
- Tel
- 0757-85921206 18520245316
- 2329783215@qq.com
More
Less
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile(2374700-40-8)Related Product Information
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
- 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
- Ethanone, 2-methoxy-1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity 85
- butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- 4-Amino-2,6-dichloropyrimidine
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
- methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride
- N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one
- Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride
- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-7-[(4-methylphenyl)sulfonyl]-N-[(3R,4R)-4-methyl-3-piperidinyl]-
- Tofacitinib Impurity 29
- Tofacitinib Impurity 2
- (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester